Free Trial
NASDAQ:BGM

Qilian International Holding Group (BGM) Stock Price, News & Analysis

$7.15
+0.15 (+2.14%)
(As of 11/1/2024 ET)

About Qilian International Holding Group Stock (NASDAQ:BGM)

Key Stats

Today's Range
$6.40
$7.47
50-Day Range
$5.50
$8.31
52-Week Range
$1.78
$8.96
Volume
25,650 shs
Average Volume
16,531 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Receive BGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qilian International Holding Group and its competitors with MarketBeat's FREE daily newsletter.

BGM Stock News Headlines

See More Headlines

BGM Stock Analysis - Frequently Asked Questions

Qilian International Holding Group's stock was trading at $5.5101 at the start of the year. Since then, BGM shares have increased by 29.8% and is now trading at $7.15.
View the best growth stocks for 2024 here
.

Shares of BGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qilian International Holding Group investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Today
11/02/2024
Next Earnings (Estimated)
2/20/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BGM
Fax
N/A
Employees
298
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$46.47 million
Cash Flow
$0.31 per share

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
1.41
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NASDAQ:BGM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners